Smyth MJ - Search Results

1

Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer.

Brooks J, Fleischmann-Mundt B, Woller N, Niemann J, Ribback S, Peters K, Demir IE, Armbrecht N, Ceyhan GO, Manns MP, Wirth TC, Kubicka S, Bernhardt G, Smyth MJ, Calvisi DF, Gürlevik E, Kühnel F. Brooks J, et al. Among authors: smyth mj. Cancer Res. 2018 Jan 15;78(2):475-488. doi: 10.1158/0008-5472.CAN-17-2415. Epub 2017 Nov 27. Cancer Res. 2018. PMID: 29180478

2

Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer.

Seki N, Hayakawa Y, Brooks AD, Wine J, Wiltrout RH, Yagita H, Tanner JE, Smyth MJ, Sayers TJ. Seki N, et al. Among authors: smyth mj. Cancer Res. 2003 Jan 1;63(1):207-13. Cancer Res. 2003. PMID: 12517799

3

Inhibition of early tumor growth requires J alpha 18-positive (natural killer T) cells.

Stewart TJ, Smyth MJ, Fernando GJ, Frazer IH, Leggatt GR. Stewart TJ, et al. Among authors: smyth mj. Cancer Res. 2003 Jun 15;63(12):3058-60. Cancer Res. 2003. PMID: 12810627

4

Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma.

Street SE, Zerafa N, Iezzi M, Westwood JA, Stagg J, Musiani P, Smyth MJ. Street SE, et al. Among authors: smyth mj. Cancer Res. 2007 Jun 1;67(11):5454-60. doi: 10.1158/0008-5472.CAN-06-4084. Cancer Res. 2007. PMID: 17545627

5

Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.

Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ. Teng MW, et al. Among authors: smyth mj. Cancer Res. 2007 Aug 1;67(15):7495-504. doi: 10.1158/0008-5472.CAN-07-0941. Cancer Res. 2007. PMID: 17671220

6

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.

Moeller M, Kershaw MH, Cameron R, Westwood JA, Trapani JA, Smyth MJ, Darcy PK. Moeller M, et al. Among authors: smyth mj. Cancer Res. 2007 Dec 1;67(23):11428-37. doi: 10.1158/0008-5472.CAN-07-1141. Cancer Res. 2007. PMID: 18056471

7

Interleukin 21 enhances antibody-mediated tumor rejection.

Smyth MJ, Teng MW, Sharkey J, Westwood JA, Haynes NM, Yagita H, Takeda K, Sivakumar PV, Kershaw MH. Smyth MJ, et al. Cancer Res. 2008 Apr 15;68(8):3019-25. doi: 10.1158/0008-5472.CAN-07-6019. Cancer Res. 2008. PMID: 18413772

8

Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

Klages K, Mayer CT, Lahl K, Loddenkemper C, Teng MW, Ngiow SF, Smyth MJ, Hamann A, Huehn J, Sparwasser T. Klages K, et al. Among authors: smyth mj. Cancer Res. 2010 Oct 15;70(20):7788-99. doi: 10.1158/0008-5472.CAN-10-1736. Epub 2010 Oct 5. Cancer Res. 2010. PMID: 20924102

9

Tumor ablation by gene-modified T cells in the absence of autoimmunity.

Wang LX, Westwood JA, Moeller M, Duong CP, Wei WZ, Malaterre J, Trapani JA, Neeson P, Smyth MJ, Kershaw MH, Darcy PK. Wang LX, et al. Among authors: smyth mj. Cancer Res. 2010 Dec 1;70(23):9591-8. doi: 10.1158/0008-5472.CAN-10-2884. Epub 2010 Nov 23. Cancer Res. 2010. PMID: 21098715

10

Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases.

Teng MW, von Scheidt B, Duret H, Towne JE, Smyth MJ. Teng MW, et al. Among authors: smyth mj. Cancer Res. 2011 Mar 15;71(6):2077-86. doi: 10.1158/0008-5472.CAN-10-3994. Epub 2011 Jan 31. Cancer Res. 2011. PMID: 21282337

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

662 results

Search Page